Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

FDG PET/CT As a Diagnostic and Prognostic Tool for the Evaluation of Marginal Zone Lymphoma

Iuliana Vaxman, MDBA, Hanna Bernstine, Geffen Kleinstern, PhD, Natav Hendin, Shai Shimony, MD, Liran Domachevsky, Ronit Gurion, David Groshar, MD, Pia Raanani, Anat Gafter-Gvili

Blood (2018) 132 (Supplement 1): 1608.

https://doi.org/10.1182/blood-2018-99-113814

Published: 2018

Journal Articles

The Role of PET-CT for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Febrile Neutropenia

Anat Gafter-Gvili, MD, Mical Paul, MD, Hanna Bernstine, MD, Liat Vidal, MD, Ron Ram, MD, Pia Raanani, MD, Moshe Yeshurun, MD, Boaz Tadmor, MD, Ofer Shpilberg, MD, MPH, David Groshar, MD

Blood (2011) 118 (21): 4289.

https://doi.org/10.1182/blood.V118.21.4289.4289

Published: 2011

Journal Articles

Limited PET-CT May Be Adequate for Interim and End of Therapy Response Assessment in Patients with Early Stage Hodgkin and Aggressive Non-Hodgkin Lymphoma - A Retrospective Single Center Study

Ofir Wolach, MD, Hana Berenstine, MD, Yonatan Edel, MD, Osnat Bairey, MD, Ofer Shpilberg, MD, MPH, David Groshar, MD, Meir Lahav, MD

Blood (2011) 118 (21): 1562.

https://doi.org/10.1182/blood.V118.21.1562.1562

Published: 2011

Journal Articles

The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography and CT (PET-CT) for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Neutropenia and Fever.

Anat Gafter-Gvili, MD, Hanna Bernstine, MD, Liat Vidal, MD, Mical Paul, MD, Ron Ram, MD, Pia Raanani, MD, Moshe Yeshurun, Ofer Shpilberg, MD, MPH, David Groshar, MD

Blood (2009) 114 (22): 3121.

https://doi.org/10.1182/blood.V114.22.3121.3121

Published: 2009

Journal Articles

Pulmonary Infiltrates in NHL Patients Receiving Rituximab Combined with Chemotherapy: 18F-Fluorodeoxyglucose Positron Emission Tomography and CT (PET-CT) Analysis and Clinical Correlates.

Yael C Cohen, MD, Tamar Cohen-Berger, MD, Lora Eshel, MD, Dorit Stern, MD, Osnat Bairey, MD, Pia Raanani, MD, Hanna Bernstine, MD, Ofer Shpilberg, MD, MPH, David Groshar, MD

Blood (2009) 114 (22): 3753.

https://doi.org/10.1182/blood.V114.22.3753.3753

Published: 2009

NARROW

FDG PET/CT As a Diagnostic and Prognostic Tool for the Evaluation of Marginal Zone Lymphoma

The Role of PET-CT for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Febrile Neutropenia

Limited PET-CT May Be Adequate for Interim and End of Therapy Response Assessment in Patients with Early Stage Hodgkin and Aggressive Non-Hodgkin Lymphoma - A Retrospective Single Center Study

The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography and CT (PET-CT) for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Neutropenia and Fever.

Pulmonary Infiltrates in NHL Patients Receiving Rituximab Combined with Chemotherapy: 18F-Fluorodeoxyglucose Positron Emission Tomography and CT (PET-CT) Analysis and Clinical Correlates.

Email alerts

ASH Publications

American Society of Hematology

FDG PET/CT As a Diagnostic and Prognostic Tool for the Evaluation of Marginal Zone Lymphoma

The Role of PET-CT for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Febrile Neutropenia

Limited PET-CT May Be Adequate for Interim and End of Therapy Response Assessment in Patients with Early Stage Hodgkin and Aggressive Non-Hodgkin Lymphoma - A Retrospective Single Center Study

The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography and CT (PET-CT) for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Neutropenia and Fever.

Pulmonary Infiltrates in NHL Patients Receiving Rituximab Combined with Chemotherapy: 18F-Fluorodeoxyglucose Positron Emission Tomography and CT (PET-CT) Analysis and Clinical Correlates.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only